SegRap2025:鼻咽癌放疗计划中GTV和淋巴结临床靶区体积分割的基准测试
SegRap2025: A Benchmark of Gross Tumor Volume and Lymph Node Clinical Target Volume Segmentation for Radiotherapy Planning of Nasopharyngeal Carcinoma
AI总结:
SegRap2025旨在通过多中心、多模态的基准测试提升鼻咽癌放疗计划中GTV和LN CTV分割的通用性和鲁棒性。
摘要:
准确从CT扫描中勾画出肿瘤总病灶体积(GTV)、淋巴结临床靶区体积(LN CTV)和易受损伤的器官(OAR)对于鼻咽癌(NPC)的精确放疗计划至关重要。在SegRap2023的基础上,后者专注于使用单中心配对非增强CT(ncCT)和增强CT(ceCT)扫描进行OAR和GTV分割,SegRap2025挑战旨在提高分割模型在不同影像中心和模态下的通用性和鲁棒性。SegRap2025包含两个任务:任务01使用SegRap2023数据集的配对CT进行GTV分割,并增加一个外部测试集以评估跨中心泛化能力;任务02则专注于使用多中心训练数据和未见过的外部测试集进行LN CTV分割,每个案例包含配对CT扫描或单一模态,强调跨中心和跨模态的鲁棒性。本文提出了挑战设置,并提供了十支参赛队伍提交的解决方案的全面分析。对于GTV分割任务,表现最佳的模型在内部和外部测试组中的平均Dice相似系数(DSC)分别为74.61%和56.79%。对于LN CTV分割任务,最高平均DSC值分别达到60.24%、60.50%和57.23%,分别对应配对CT、ceCT-only和ncCT-only子集。SegRap2025建立了大规模多中心、多模态的基准测试,用于评估放疗目标分割的通用性和鲁棒性,为临床可应用的自动化放疗计划系统提供了有价值的见解。该基准测试可在:https://hilab-git.github.io/SegRap2025_Challenge访问。
英文摘要:
Accurate delineation of Gross Tumor Volume (GTV), Lymph Node Clinical Target Volume (LN CTV), and Organ-at-Risk (OAR) from Computed Tomography (CT) scans is essential for precise radiotherapy planning in Nasopharyngeal Carcinoma (NPC). Building upon SegRap2023, which focused on OAR and GTV segmentation using single-center paired non-contrast CT (ncCT) and contrast-enhanced CT (ceCT) scans, the SegRap2025 challenge aims to enhance the generalizability and robustness of segmentation models across imaging centers and modalities. SegRap2025 comprises two tasks: Task01 addresses GTV segmentation using paired CT from the SegRap2023 dataset, with an additional external testing set to evaluate cross-center generalization, and Task02 focuses on LN CTV segmentation using multi-center training data and an unseen external testing set, where each case contains paired CT scans or a single modality, emphasizing both cross-center and cross-modality robustness. This paper presents the challenge setup and provides a comprehensive analysis of the solutions submitted by ten participating teams. For GTV segmentation task, the top-performing models achieved average Dice Similarity Coefficient (DSC) of 74.61% and 56.79% on the internal and external testing cohorts, respectively. For LN CTV segmentation task, the highest average DSC values reached 60.24%, 60.50%, and 57.23% on paired CT, ceCT-only, and ncCT-only subsets, respectively. SegRap2025 establishes a large-scale multi-center, multi-modality benchmark for evaluating the generalization and robustness in radiotherapy target segmentation, providing valuable insights toward clinically applicable automated radiotherapy planning systems. The benchmark is available at: https://hilab-git.github.io/SegRap2025_Challenge.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。